Compare AOUT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOUT | ORMP |
|---|---|---|
| Founded | 2020 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.3M | 141.3M |
| IPO Year | 2020 | 2010 |
| Metric | AOUT | ORMP |
|---|---|---|
| Price | $8.71 | $4.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | 25.7K | ★ 158.2K |
| Earning Date | 03-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 98.94 | ★ 412.50 |
| EPS | N/A | ★ 1.50 |
| Revenue | ★ $222,322,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.06 | N/A |
| P/E Ratio | ★ N/A | $3.13 |
| Revenue Growth | 10.55 | ★ 49.25 |
| 52 Week Low | $6.26 | $1.98 |
| 52 Week High | $13.46 | $5.01 |
| Indicator | AOUT | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 69.57 |
| Support Level | $8.33 | $3.21 |
| Resistance Level | $8.91 | N/A |
| Average True Range (ATR) | 0.42 | 0.22 |
| MACD | -0.10 | 0.07 |
| Stochastic Oscillator | 19.60 | 68.64 |
American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.